Life sciences incubator and company builder Pivotal Bioventure Partners China, part of Nan Fung Group, has closed its latest fund at $150m.
Pivotal Bioventure Partners China, a China-based life sciences investment vehicle set up by property development group Nan Fung, has closed its latest fund at $150m.
Pivotal incubates and builds life sciences technology companies, focusing on pharmaceuticals, medical devices and healthcare services capable of meeting the requirements of the Chinese market.
Overseen by Nan Fung subsidiary Nan Fung Life Sciences, the firm primarily looks to license innovative technologies that will form the basis of new companies that will then use them…
